Moderna Therapeutics, Inc. CFO sold: $14.05m-June 2
Apparently they are still watching Pron at the SEC and not much else
CFO bailing effective June 8th
following sales on May12,15 and 18 of $36.64m
Has 1.20m in shares on this registration left after this sale. This was muh options execution of 241k shares at $17.55/sh and sale at $58.30/sh
Watchdog urges SEC to investigate vaccine maker Moderna
https://www.cbsnews.com/news/insider-trading-allegations-moderna-accountable-us-securities-exchange-commission/
Moderna Hires New CFO Amid Race To Develop Coronavirus Treatment
https://www.forbes.com/sites/ezequielminaya/2020/06/04/moderna-hires-new-cfo-amid-race-to-develop-coronavirus-treatment/#68a913a05dc8
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics. Number of employees : 830 people.
https://www.marketscreener.com/MODERNA-INC-47437573/company/
https://www.finviz.com/insidertrading.ashx?oc=1643746&tc=7&b=2